HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Philip Maes Selected Research
Philip Maes Research Topics
Disease
3
Sickle Cell Anemia (Hemoglobin S Disease)
01/2021 - 04/2005
2
Hemophilia A (Haemophilia)
08/2020 - 01/2018
1
von Willebrand Diseases (von Willebrand's Disease)
04/2022
1
Pain (Aches)
01/2021
1
Hyperbilirubinemia
01/2021
1
Hypoxia (Hypoxemia)
01/2021
1
Thalassemia
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2017
1
Hypersensitivity (Allergy)
10/2017
1
Infections
10/2017
1
Leukemia
10/2017
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2017
1
Neoplasms (Cancer)
10/2017
1
Neurologic Manifestations (Neurological Manifestations)
05/2014
1
Encephalitis (Encephalitis, Rasmussen)
05/2014
1
Anemia
04/2005
Drug/Important Bio-Agent (IBA)
1
von Willebrand Factor
IBA
04/2022
1
Factor VIII (Coagulation Factor VIII)
IBA
04/2022
1
Sickle Hemoglobin
IBA
01/2021
1
Ticagrelor
IBA
01/2021
1
Poloxamer (Poloxamer 407)
IBA
01/2021
1
human F8 protein
FDA Link
08/2020
1
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2018
1
Asparaginase (Elspar)
FDA Link
10/2017
1
Proteins (Proteins, Gene)
FDA Link
05/2014
1
Hemoglobins (Hemoglobin)
IBA
04/2005
1
Biological Products
IBA
04/2005
1
Hydroxyurea (Hydrea)
FDA Link
Generic
04/2005
Therapy/Procedure
2
Therapeutics
01/2021 - 10/2017
1
Combination Drug Therapy (Combination Chemotherapy)
10/2017
1
Drug Therapy (Chemotherapy)
04/2005